Alpha Tau Medical Ltd. (DRTS) Develops Targeted Cancer TherapyAlpha Tau Medical LtdNASDAQ:DRTStraderspro_chartsAlpha Tau Medical Ltd. (DRTS) develops targeted alpha radiation therapies designed to treat solid tumors with precision while minimizing damage to surrounding healthy tissue. Its lead technology delivers radiation directly into tumors, offering a novel approach to cancer treatment. Growth is driven by clinical progress, expanding indications, and rising demand for advanced oncology therapies. On the chart, DRTS printed a confirmation bar with increasing volume as price moved above the .236 Fibonacci level and into the momentum zone. A trailing stop can be established using Fibonacci levels on the Fibonacci snap tool, helping manage risk while allowing momentum to continue.